arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

Coronavirus Fraud Nears $150 Million in Losses in US

The Federal Trade Commission (FTC) has received more than 200,000 complaints so far this year about fraud related to the COVID-19 pandemic, with losses in the US totaling more than $146 million as of September 24, 2020.  According to the Commission’s Consumer Sentinel Network, which has been tracking complaints since January 1, 2020, the median…

Continue Reading ›

While Many Industries Are Suffering, 2020 May Be the Year of the Supplement

The supplement industry grew by $345 million in 2019, which added to steady growth for the $32 billion industry. But that’s small potatoes compared to the first few months of 2020, in which supplement sales surged a whopping $586 million by mid-May alone, according to healthcare executive Kristin Hornberger of IRI Worldwide in a recent…

Continue Reading ›

LegitScript Waives Some Certification Fees to Help Telehealth Providers Meet Pandemic Demand

LegitScript’s mission — making the internet and payments ecosystems safer and more transparent — is more important than ever in the midst of the ongoing pandemic related to the novel coronavirus. As you may have read in the media or with our own reporting, there is a lot going on with cybercrime related to the…

Continue Reading ›

Bogus Cures and Unapproved Treatments for COVID-19 Flood the Internet

With the COVID-19 pandemic sweeping across the globe, the payments and e-commerce landscapes are especially vulnerable right now to scammers preying on consumers with fake cures, unapproved treatments, and other unconventional products and services to treat the new coronavirus. These scams are not only detrimental to public health but also pose serious risks of chargebacks…

Continue Reading ›

As Coronavirus Spreads, So Do Fake, Unapproved, and Ineffective Test Kits

LegitScript has been proactively monitoring the online space in response to the outbreak of the virus SARS-CoV-2, which causes COVID-19, and has identified an increasing trend in the marketing of coronavirus-related products that present an elevated risk to consumers, payment service providers, and e-commerce platforms. In particular, the severe shortage of diagnostic kits to test…

Continue Reading ›

New Warning Letters Signal Forceful Approach to Containing Coronavirus Treatment Claims

The Federal Trade Commission (FTC) and US Food and Drug Administration (FDA) announced Monday seven warning letters they issued jointly to business owners making potentially problematic claims that their products can treat or prevent the new coronavirus. These letters appear to reflect aggressive action by the federal agencies to stop businesses capitalizing on COVID-19 fears…

Continue Reading ›